Today, only one in nine compounds makes it successfully through the pharmaceutical development process and gets approved by the European and/or the U.S. regulatory authorities. The vast majority of ...
“The public outcome of compound claim cases indicates that the success rate is much lower when compared with challenges of other types of claims.” Patent challenges are an indispensable part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback